AAAAAA

   
Results: 1-14 |
Results: 14
Waldenstrom macroglobulinemia - Development of diagnostic criteria and identification of prognostic factors
Authors: Owen, RG Barrans, SL Richards, SJ O'Connor, SJM Child, JA Parapia, LA Morgan, GJ Jack, AS
Citation: Rg. Owen et al., Waldenstrom macroglobulinemia - Development of diagnostic criteria and identification of prognostic factors, AM J CLIN P, 116(3), 2001, pp. 420-428
Fast-track referral system for patients with haematological malignancy
Authors: Follows, GA Child, JA Smith, GM
Citation: Ga. Follows et al., Fast-track referral system for patients with haematological malignancy, CLIN LAB H, 23(5), 2001, pp. 333-334
Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
Authors: Casassus, P Gibson, J Joshua, DE Matthews, J Diaz, JC Gertz, MA Kyle, R Leong, T Oken, MM Fritz, E Ludwig, H Corrado, C Lastiri, F Peest, D Grosbois, B Vela-Ojeda, J Avvisati, G Mandelli, F Petrucci, MT Capnist, G Child, JA Drayson, MT Dunn, J MacLennan, I Mellstedt, H Osterborg, A Rodjer, S Turesson, I Westin, J Bergsagel, D Browman, GP Shustik, C Zee, B Hjorth, M Holmberg, E Rodjer, S Turesson, I Westin, J Alison, R Clarke, M Elphinstone, P Evans, V Gray, R Hicks, C James, S MacKinnon, L Peto, R Richards, S Wheatley, K Blade, J Fontanillas, M San Miguel, J Aitchison, R Newland, AC Cunningham, D Malpas, J Powles, RL Montuoro, A Jacobson, J Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression
Authors: Rawstron, AC Barrans, SL Blythe, D English, A Richards, SJ Fenton, JAL Davies, FE Child, JA Jack, AS Morgan, GJ
Citation: Ac. Rawstron et al., In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression, BR J HAEM, 113(3), 2001, pp. 794-802
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
Authors: Davies, FE Forsyth, PD Rawstron, AC Owen, RG Pratt, G Evans, PAS Richards, SJ Drayson, M Smith, GM Selby, PJ Child, JA Morgan, GJ
Citation: Fe. Davies et al., The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma, BR J HAEM, 112(3), 2001, pp. 814-819
Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma
Authors: Dring, AM Davies, FE Rollinson, SJ Roddam, PL Rawstron, AC Child, JA Jack, AS Morgan, GJ
Citation: Am. Dring et al., Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma, BR J HAEM, 112(1), 2001, pp. 249-250
FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
Authors: Child, JA Johnson, SA Rule, S Smith, GM Morgan, GJ Johnson, PWM Prentice, AG Tollerfield, SM Wareham, E
Citation: Ja. Child et al., FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 37(3-4), 2000, pp. 309-317
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
Authors: Davies, FE Rollinson, SJ Rawstron, AC Roman, E Richards, S Drayson, M Child, JA Morgan, GJ
Citation: Fe. Davies et al., High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment, J CL ONCOL, 18(15), 2000, pp. 2843-2851
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
Authors: Davies, FE Rawstron, AC Pratt, G Coupe, R Clarke, D Lubenko, A Short, K Perren, TJ Selby, PJ MacLennan, S Major, K Woodhead, V Robinson, F Child, JA Smith, GM Johnson, PWM Morgan, GJ
Citation: Fe. Davies et al., Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests, HEMATOL ONC, 18(3), 2000, pp. 111-120
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells
Authors: Rawstron, AC Fenton, JAL Ashcroft, J English, A Jones, RA Richards, SJ Pratt, G Owen, R Davies, FE Child, JA Jack, AS Morgan, G
Citation: Ac. Rawstron et al., The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells, BLOOD, 96(12), 2000, pp. 3880-3886
FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells
Authors: Davies, FE Rawstron, AC Pratt, G O'Connor, S Su'ut, L Blythe, D Fenton, J Claydon, D Child, JA Jack, AS Morgan, GJ
Citation: Fe. Davies et al., FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells, BR J HAEM, 106(1), 1999, pp. 40-46
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma
Authors: Stead, ML Brown, JM Velikova, G Kaasa, S Wisloff, F Child, JA Hippe, E Hjorth, M Sezer, O Selby, P
Citation: Ml. Stead et al., Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma, BR J HAEM, 104(3), 1999, pp. 605-611
Liposomal daunorubicin: In vitro and in vivo efficacy in multiple myeloma
Authors: Pratt, G Wiles, ME Rawstron, AC Davies, FE Fenton, JAL Proffitt, JA Child, JA Smith, GM Morgan, GJ
Citation: G. Pratt et al., Liposomal daunorubicin: In vitro and in vivo efficacy in multiple myeloma, HEMATOL ONC, 16(2), 1998, pp. 47-55
True spectrum of 14q32 translocations in multiple myeloma
Authors: Pratt, G Fenton, JAL Proffitt, JA Rawstron, AC Davies, FE Child, JA Morgan, GJ
Citation: G. Pratt et al., True spectrum of 14q32 translocations in multiple myeloma, BR J HAEM, 103(4), 1998, pp. 1209-1210
Risultati: 1-14 |